Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer. [electronic resource] by
- Du, Xiangnan
- Lin, Benjamin C
- Wang, Qian-Rena
- Li, Hao
- Ingalla, Ellen
- Tien, Janet
- Rooney, Isabelle
- Ashkenazi, Avi
- Penuel, Elicia
- Qing, Jing
Producer: 20151117
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
|
5.
|
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib. [electronic resource] by
- Wongchenko, Matthew J
- Ribas, Antoni
- Dréno, Brigitte
- Ascierto, Paolo A
- McArthur, Grant A
- Gallo, Jorge D
- Rooney, Isabelle A
- Hsu, Jessie
- Koeppen, Hartmut
- Yan, Yibing
- Larkin, James
Producer: 20190207
In:
Pigment cell & melanoma research vol. 31
Availability: No items available.
|
|
|
6.
|
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer. [electronic resource] by
- Schöffski, Patrick
- Cresta, Sara
- Mayer, Ingrid A
- Wildiers, Hans
- Damian, Silvia
- Gendreau, Steven
- Rooney, Isabelle
- Morrissey, Kari M
- Spoerke, Jill M
- Ng, Vivian W
- Singel, Stina M
- Winer, Eric
Producer: 20190528
In:
Breast cancer research : BCR vol. 20
Availability: No items available.
|
|
|
7.
|
Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans. [electronic resource] by
- Takahashi, Ryan H
- Choo, Edna F
- Ma, Shuguang
- Wong, Susan
- Halladay, Jason
- Deng, Yuzhong
- Rooney, Isabelle
- Gates, Mary
- Hop, Cornelis E C A
- Khojasteh, S Cyrus
- Dresser, Mark J
- Musib, Luna
Producer: 20160913
In:
Drug metabolism and disposition: the biological fate of chemicals vol. 44
Availability: No items available.
|
|
|
8.
|
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in [electronic resource] by
- Ribas, Antoni
- Daud, Adil
- Pavlick, Anna C
- Gonzalez, Rene
- Lewis, Karl D
- Hamid, Omid
- Gajewski, Thomas F
- Puzanov, Igor
- Wongchenko, Matthew
- Rooney, Isabelle
- Hsu, Jessie J
- Yan, Yibing
- Park, Erica
- McArthur, Grant A
Producer: 20201001
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
9.
|
Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. [electronic resource] by
- Lewis, Hal A
- Zhao, Xun
- Wang, Chi
- Sauder, J Michael
- Rooney, Isabelle
- Noland, Brian W
- Lorimer, Don
- Kearins, Margaret C
- Conners, Kris
- Condon, Brad
- Maloney, Peter C
- Guggino, William B
- Hunt, John F
- Emtage, Spencer
Producer: 20050225
In:
The Journal of biological chemistry vol. 280
Availability: No items available.
|
|
|
10.
|
Gene Expression Profiling in [electronic resource] by
- Wongchenko, Matthew J
- McArthur, Grant A
- Dréno, Brigitte
- Larkin, James
- Ascierto, Paolo A
- Sosman, Jeffrey
- Andries, Luc
- Kockx, Mark
- Hurst, Stephen D
- Caro, Ivor
- Rooney, Isabelle
- Hegde, Priti S
- Molinero, Luciana
- Yue, Huibin
- Chang, Ilsung
- Amler, Lukas
- Yan, Yibing
- Ribas, Antoni
Producer: 20180619
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
|
11.
|
Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with [electronic resource] by
- Yan, Yibing
- Wongchenko, Matthew J
- Robert, Caroline
- Larkin, James
- Ascierto, Paolo A
- Dréno, Brigitte
- Maio, Michele
- Garbe, Claus
- Chapman, Paul B
- Sosman, Jeffrey A
- Shi, Zhen
- Koeppen, Hartmut
- Hsu, Jessie J
- Chang, Ilsung
- Caro, Ivor
- Rooney, Isabelle
- McArthur, Grant A
- Ribas, Antoni
Producer: 20200706
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
12.
|
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF [electronic resource] by
- Dréno, Brigitte
- Ascierto, Paolo A
- Atkinson, Victoria
- Liszkay, Gabriella
- Maio, Michele
- Mandalà, Mario
- Demidov, Lev
- Stroyakovskiy, Daniil
- Thomas, Luc
- de la Cruz-Merino, Luis
- Dutriaux, Caroline
- Garbe, Claus
- Bartley, Karen
- Karagiannis, Thomas
- Chang, Ilsung
- Rooney, Isabelle
- Koralek, Daniel O
- Larkin, James
- McArthur, Grant A
- Ribas, Antoni
Producer: 20190415
In:
British journal of cancer vol. 118
Availability: No items available.
|
|
|
13.
|
Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. [electronic resource] by
- Ascierto, Paolo A
- McArthur, Grant A
- Dréno, Brigitte
- Atkinson, Victoria
- Liszkay, Gabrielle
- Di Giacomo, Anna Maria
- Mandalà, Mario
- Demidov, Lev
- Stroyakovskiy, Daniil
- Thomas, Luc
- de la Cruz-Merino, Luis
- Dutriaux, Caroline
- Garbe, Claus
- Yan, Yibing
- Wongchenko, Matthew
- Chang, Ilsung
- Hsu, Jessie J
- Koralek, Daniel O
- Rooney, Isabelle
- Ribas, Antoni
- Larkin, James
Producer: 20170605
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|
|
|
14.
|
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. [electronic resource] by
- Buchanan, Sean G
- Hendle, Jorg
- Lee, Patrick S
- Smith, Christopher R
- Bounaud, Pierre-Yves
- Jessen, Katti A
- Tang, Crystal M
- Huser, Nanni H
- Felce, Jeremy D
- Froning, Karen J
- Peterman, Marshall C
- Aubol, Brandon E
- Gessert, Steve F
- Sauder, J Michael
- Schwinn, Kenneth D
- Russell, Marijane
- Rooney, Isabelle A
- Adams, Jason
- Leon, Barbara C
- Do, Tuan H
- Blaney, Jeff M
- Sprengeler, Paul A
- Thompson, Devon A
- Smyth, Lydia
- Pelletier, Laura A
- Atwell, Shane
- Holme, Kevin
- Wasserman, Stephen R
- Emtage, Spencer
- Burley, Stephen K
- Reich, Siegfried H
Producer: 20100324
In:
Molecular cancer therapeutics vol. 8
Availability: No items available.
|
|
|
15.
|
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. [electronic resource] by
- McQuade, Jennifer L
- Daniel, Carrie R
- Hess, Kenneth R
- Mak, Carmen
- Wang, Daniel Y
- Rai, Rajat R
- Park, John J
- Haydu, Lauren E
- Spencer, Christine
- Wongchenko, Matthew
- Lane, Stephen
- Lee, Dung-Yang
- Kaper, Mathilde
- McKean, Meredith
- Beckermann, Kathryn E
- Rubinstein, Samuel M
- Rooney, Isabelle
- Musib, Luna
- Budha, Nageshwar
- Hsu, Jessie
- Nowicki, Theodore S
- Avila, Alexandre
- Haas, Tomas
- Puligandla, Maneka
- Lee, Sandra
- Fang, Shenying
- Wargo, Jennifer A
- Gershenwald, Jeffrey E
- Lee, Jeffrey E
- Hwu, Patrick
- Chapman, Paul B
- Sosman, Jeffrey A
- Schadendorf, Dirk
- Grob, Jean-Jacques
- Flaherty, Keith T
- Walker, Dana
- Yan, Yibing
- McKenna, Edward
- Legos, Jeffrey J
- Carlino, Matteo S
- Ribas, Antoni
- Kirkwood, John M
- Long, Georgina V
- Johnson, Douglas B
- Menzies, Alexander M
- Davies, Michael A
Producer: 20190226
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|